GenMont BiotechTPE:3164 +0.30%83 OCF Margin % is 49.12% as of Dec. 2025, which is 134% above its 10-year median of 20.95. GuruFocus rates TPE:3164 with a GF Score™ of 83/100 and a GF Value™ of NT$26.24 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 948 Biotechnology companies, GenMont Biotech ranks better than 82.28% on this metric.
The historical rank and industry rank for GenMont Biotech's OCF Margin % or its related term are showing as below:
TPE:3164'
s OCF Margin % Range Over the Past 10 Years
Min: 8.38 Med: 20.95 Max: 37.17
Current: 18.34
During the past 13 years, the highest OCF Margin % of GenMont Biotech was 37.17%. The lowest was 8.38%. And the median was 20.95%.
TPE:3164's OCF Margin % is ranked better than 82.28% of 948
companies
in the Biotechnology industry
Industry Median: -64.115
vs TPE:3164: 18.34
GenMont Biotech OCF Margin % Related Terms
GenMont Biotech OCF Margin % Historical Data
* Premium members only.
The historical data trend for GenMont Biotech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3164 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, GenMont Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GenMont Biotech OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GenMont Biotech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where GenMont Biotech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenMont Biotech (TPE:3164) has a OCF Margin % of 49.12% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GenMont Biotech and its competitors. This is 134% above median its historical median of 20.95. Over the past decade, GenMont Biotech's OCF Margin % has ranged from 8.38 to 37.17. According to the industry distribution chart, GenMont Biotech ranks #168 out of 948 companies in the Biotechnology industry, placing it in the top 17.7%.
Is GenMont Biotech's OCF Margin % too high?
GenMont Biotech's current OCF Margin % of 49.12% is 134% above median its 10-year median of 20.95. Over the past 10 years, this metric has ranged from a low of 8.38 to a high of 37.17. Based on the distribution chart, GenMont Biotech ranks #168 out of 948 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GenMont Biotech has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GenMont Biotech ranks #168 out of 948 companies for OCF Margin %. This places GenMont Biotech in the top 18% of its industry — outperforming the majority of peers. Historically, GenMont Biotech's own OCF Margin % has ranged from 8.38 to 37.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GenMont Biotech and its competitors. GenMont Biotech's current OCF Margin % is 49.12%, which is 134% above median its own 10-year median of 20.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$26.24, compared to a current price of NT$16.55 — trading 36.9% below its estimated fair value. The current OCF Margin % is 49.12%, which is 134% above median its 10-year median of 20.95. GenMont Biotech's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current OCF Margin % is 49.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GenMont Biotech (TPE:3164) Overvalued in 2026?
Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued.
The current stock price of NT$16.55 is trading 36.9% below its estimated GF Value™ of NT$26.24.
GuruFocus considers GenMont Biotech to be Significantly Undervalued.
Key valuation signals for TPE:3164:
OCF Margin %: 49.12% (134% above median its 10-year median of 20.95)
GF Value™: NT$26.24 vs. price of NT$16.55 (36.9% below fair value)
No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
83GF Score
Get the complete analysis for TPE:3164
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3164 has been successfully added to your 
